Kainos Medicine, Inc. announced a private placement of 1,033,592 common shares at an issue price of KRW 1,935 per share for gross proceeds of KRW 2,000,000,520 on June 15, 2022. The transaction will involve participation from existing investor, SC United Co., Ltd. The payment date is June 23, 2022. The transaction has been approved by the board of directors of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,895 KRW | -5.08% | +7.02% | -32.99% |
2023 | Kainos Medicine, Inc.(KOSDAQ:A284620) dropped from S&P Global BMI Index | CI |
2022 | Kainos Medicine, Inc. announced that it has received KRW 2.00000052 billion in funding from SC United Co., Ltd. | CI |
1st Jan change | Capi. | |
---|---|---|
-32.99% | 58.73M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- A284620 Stock
- News Kainos Medicine, Inc.
- Kainos Medicine, Inc. announced that it expects to receive KRW 2.00000052 billion in funding from SC United Co., Ltd.